Neurological events Infliximab and other agents that inhibit TNFα have been associated in rare cases with optic neuritis, seizure and new onset or exacerbation of clinical symptoms and/ or radiographic evidence of central nervous system demyelinating disorders, including multiple sclerosis, and peripheral demyelinating disorders, including Guillain-Barré syndrome.